97 related articles for article (PubMed ID: 29476413)
1. A Real-World Anti-Diabetes Medication Cost Comparison Between Premixed Insulin Analogs and Long-Acting Insulin Analogs in Chinese Patients with Type 2 Diabetes: A Retrospective Database Analysis.
Gao Y; Wang K; Chen Y; Shen L; Hou J; Xuan J; Liu B
Diabetes Ther; 2018 Apr; 9(2):673-682. PubMed ID: 29476413
[TBL] [Abstract][Full Text] [Related]
2. Association of Initiation of Basal Insulin Analogs vs Neutral Protamine Hagedorn Insulin With Hypoglycemia-Related Emergency Department Visits or Hospital Admissions and With Glycemic Control in Patients With Type 2 Diabetes.
Lipska KJ; Parker MM; Moffet HH; Huang ES; Karter AJ
JAMA; 2018 Jul; 320(1):53-62. PubMed ID: 29936529
[TBL] [Abstract][Full Text] [Related]
3. Insulin Fact Sheet in Type 1 and 2 Diabetes Mellitus and Trends of Antidiabetic Medication Use in Insulin Users with Type 2 Diabetes Mellitus: 2002 to 2019.
Park J; Kim G; Kim BS; Han KD; Kwon SY; Park SH; Lee YB; Jin SM; Kim JH
Diabetes Metab J; 2023 Mar; 47(2):211-219. PubMed ID: 36746784
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of the Lilly Connected Care Program in Improving Glycemic Management Among Patients With Type 2 Diabetes in China: Retrospective Real-world Study.
Su B; Chen Y; Shen X; Guo J; Ding Y; Ma X; Yang Y; Liu D
J Med Internet Res; 2023 Apr; 25():e38680. PubMed ID: 37097724
[TBL] [Abstract][Full Text] [Related]
5. Comparison of basal insulin therapies with regard to the risk of acute myocardial infarction in patients with type 2 diabetes: an observational cohort study.
Kollhorst B; Behr S; Enders D; Dippel FW; Theobald K; Garbe E
Diabetes Obes Metab; 2015 Dec; 17(12):1158-65. PubMed ID: 26279482
[TBL] [Abstract][Full Text] [Related]
6. A Real-World, Observational Study of the Initiation, Use, and Effectiveness of Basal-Bolus or Premixed Insulin in Japanese People with Type 2 Diabetes.
Miyoshi H; Baxter M; Kimura T; Hattori M; Morimoto Y; Marinkovich D; Tamiwa M; Hirose T
Diabetes Ther; 2021 May; 12(5):1341-1357. PubMed ID: 33730337
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Human Premixed and Basal Plus Short-Acting Insulin Regimens for Individuals With Type 2 Diabetes During Ramadan Fasting.
Altemimi MT; Odhaib SA; Imran HJ; Alhamza A; Almomin A; Mansour AA
Cureus; 2020 Dec; 12(12):e11976. PubMed ID: 33425548
[TBL] [Abstract][Full Text] [Related]
8. A comparison of costs among patients with type 2 diabetes mellitus who initiated therapy with exenatide or insulin glargine.
Misurski D; Lage MJ; Fabunmi R; Boye KS
Appl Health Econ Health Policy; 2009; 7(4):245-54. PubMed ID: 19905038
[TBL] [Abstract][Full Text] [Related]
9. Lixisenatide for Type 2 Diabetes Mellitus Patients Inadequately Controlled on Oral Antidiabetic Drugs: A Mixed-Treatment Comparison Meta-analysis and Cost-Utility Analysis.
Men P; Qu S; Song Z; Liu Y; Li C; Zhai S
Diabetes Ther; 2020 Aug; 11(8):1745-1755. PubMed ID: 32562244
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Characteristics Between Chinese Patients Taking Glucagon-like Peptide 1 Receptor Agonists and Insulin: A Cross-sectional Database Analysis.
Wang K; Chen Y; Strizek A; Boye K; Gu L; Liu Y; Qu S
Clin Ther; 2019 Oct; 41(10):2057-2065. PubMed ID: 31514971
[TBL] [Abstract][Full Text] [Related]
11. Drug usage patterns and treatment costs in newly-diagnosed type 2 diabetes mellitus cases, 2007 vs 2012: findings from a large US healthcare claims database analysis.
Weng W; Liang Y; Kimball ES; Hobbs T; Kong S; Sakurada B; Bouchard J
J Med Econ; 2016 Jul; 19(7):655-62. PubMed ID: 26855139
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of exenatide twice daily vs insulin glargine as add-on therapy to oral antidiabetic agents in patients with type 2 diabetes in China.
Gu S; Wang X; Qiao Q; Gao W; Wang J; Dong H
Diabetes Obes Metab; 2017 Dec; 19(12):1688-1697. PubMed ID: 28452095
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the Effect of Glycemic Control in Type 2 Diabetes Outpatients Treated With Premixed and Basal Insulin Monotherapy in China.
Liu G; Dou J; Pan Y; Yan Y; Zhu H; Lu J; Gaisano H; Ji L; He Y
Front Endocrinol (Lausanne); 2018; 9():639. PubMed ID: 30420835
[No Abstract] [Full Text] [Related]
14. Efficacy and Safety of Premixed Human Insulin Combined with Sulfonylureas in Type 2 Diabetic Patients Previously Poorly Controlled with Insulin.
Chen YH; Li HZ; Tang ZS; Xu L; Wang H; Feng B
Diabetes Ther; 2019 Apr; 10(2):463-471. PubMed ID: 30659420
[TBL] [Abstract][Full Text] [Related]
15. Delays in Insulin Initiation among Patients with Type 2 Diabetes Mellitus in Southeast China: A Retrospective, Real-World Study.
Chen P; Ma X; Chen H; Wang K; Zhou L
Diabetes Metab Syndr Obes; 2020; 13():3059-3068. PubMed ID: 32922056
[TBL] [Abstract][Full Text] [Related]
16. Effects on clinical outcomes of intensifying triple oral antidiabetic drug (OAD) therapy by initiating insulin versus enhancing OAD therapy in patients with type 2 diabetes: A nationwide population-based, propensity-score-matched cohort study.
Kuo S; Yang CT; Wu JS; Ou HT
Diabetes Obes Metab; 2019 Feb; 21(2):312-320. PubMed ID: 30187666
[TBL] [Abstract][Full Text] [Related]
17. Insulin adherence and persistence among Chinese patients with type 2 diabetes: a retrospective database analysis.
He X; Chen L; Wang K; Wu H; Wu J
Patient Prefer Adherence; 2017; 11():237-245. PubMed ID: 28243067
[TBL] [Abstract][Full Text] [Related]
18. EADSG Guidelines: Insulin Therapy in Diabetes.
Silver B; Ramaiya K; Andrew SB; Fredrick O; Bajaj S; Kalra S; Charlotte BM; Claudine K; Makhoba A
Diabetes Ther; 2018 Apr; 9(2):449-492. PubMed ID: 29508275
[TBL] [Abstract][Full Text] [Related]
19. [POET2 registry: Comparison of annual direct medical costs of treating type 2 diabetes after addition of insulin NPH or insulin glargine to oral antidiabetic therapy in the Czech Republic].
Kvapil M; Žďarská DJ; Suchopár J; Prokeš M; Brož J
Vnitr Lek; 2015 Jan; 61(1):24-32. PubMed ID: 25693613
[TBL] [Abstract][Full Text] [Related]
20. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
